课题基金 / 基金详情

项目摘要

项目成果

ELKA R GEORGIEVA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. P-glycoprotein (Pgp, ABCB1), which belongs to the ATP-binding cassette (ABC) transporter superfamily, is a mammalian plasma membrane phospho-glycoprotein encoded by the multidrug resistance 1 (MDR1) gene. Pgp plays a role in the resistance of tumors to cytotoxic drugs and is known to efflux structurally unrelated diverse amphipathic compounds from cells. Pgp is expressed both in multidrug-resistant cancer cells and also in a number of normal tissues, such as those of the liver, kidney, small intestine, colon, and brain, suggesting that the physiological role of Pgp is a protective mechanism against xenobiotics and endogenous metabolites. After exposure to a single cytotoxic drug such as one of the Vinca alkaloids, anthracyclines, taxoids, or actinomycin D, cells can over-express Pgp and exhibit the MDR phenotype. Pgp over-expression is induced not only by chemical compounds, but also by physical stress caused by X-rays and ultraviolet light irradiation, or heat shock. Approximately 50% of currently marketed drugs have been identified to be Pgp substrates and/or inhibitors. Pgp can influence the pharmacokinetics of drugs by contributing to the processes that govern absorption, distribution, metabolism, elimination, and/or toxicity (ADMET). Additionally, Pgp has been implicated in drug-drug interactions involving co-administered Pgp substrates and modulators. For instance, intestinal Pgp mediates substantial direct transepithelial excretion of drugs including paclitaxel. ABCB1 is not oligomeric, but is homologous to dimeric prokaryotic ABC transporters, such as MsbA, which has been successfully studied at ACERT by Ku-band DEER.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USE OF LIPIDIC NANODISCS FOR STRUCTURE/FUNCTION STUDIES ON MEMBRANE PROTEINS
  • 批准号:
    8364070
  • 项目类别:
  • 资助金额:
    $0.19万
  • 财政年份:
    2011
  • 负责人:
    ELKA R GEORGIEVA
  • 依托单位:
FREEZE-QUENCH STUDY ON PROTEIN CONFORMATION STATE
  • 批准号:
    8364073
  • 项目类别:
  • 资助金额:
    $4.49万
  • 财政年份:
    2011
  • 负责人:
    ELKA R GEORGIEVA
  • 依托单位:
PROBING ALPHA-SYNUCLEIN AGGREGATION
  • 批准号:
    8364109
  • 项目类别:
  • 资助金额:
    $0.99万
  • 财政年份:
    2011
  • 负责人:
    ELKA R GEORGIEVA
  • 依托单位:
PROBING BACTERIAL HOMOLOGUE OF GLUTAMATE TRANSPORTER BY PULSED DIPOLAR ESR
  • 批准号:
    8364071
  • 项目类别:
  • 资助金额:
    $5.56万
  • 财政年份:
    2011
  • 负责人:
    ELKA R GEORGIEVA
  • 依托单位:
海外基金